Global Blastomycosis Treatment Market, By Treatment (Amphotericin B, Azoles, Surgery, Others), Dosage (Tablet, Injection, Capsule, Others), Route of Administration (Intravenous, Oral, Others), Diagnosis (Chest CT Scan, Chest X-ray, Skin Biopsy, Sputum Culture and Examination, Urinary Antigen Detection, Urine culture, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Blastomycosis Treatment Market
Global blastomycosis treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6.10% in the above mentioned forecast period.
Blastomycosis is a rare fungal infection which is caused due to the inhalation of spores of the fungus Blastomyces dermatitidis. This fungus found in decaying soil and wood. It is a pulmonary infection which has severe life threatening complications such as acute respiratory distress syndrome. It is characterised by fever, cough, night sweat, joint pain, weight loss, fatigue and breathing difficulties. This fungal infection is also known as Gilchrist's Disease or North American Blastomycosis.
Rise in the prevalence of fungal infections, rise in the population of immunocompromised patients, rising healthcare expenditure, growing government initiatives, advancement in treatment options and rising awareness towards health are the factors that will expand the global blastomycosis treatment market.
Rising R&D activities, emerging markets and ongoing clinical trials will provide beneficial opportunities for the global blastomycosis treatment market in the forecast period of 2021-2028.
High cost of treatment, complication associated with blastomycosis such as disease recurrence, abscesses, skin sores and side effects of Amphotericin B such as blue lips, seizures, abdominal pain, numbness and fever are the factors that will hamper the market growth and will further challenge the global blastomycosis treatment market in the forecast period mentioned above.
This Blastomycosis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global blastomycosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Blastomycosis Treatment Market Scope and Market Size
The Blastomycosis treatment market is segmented on the basis of treatment, dosage, route of administration, diagnosis, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the blastomycosis treatment market is segmented into amphotericin B, azoles, surgery and others. Azoles have been further sub-segmented into ketoconazole, itraconazole, fluconazole, voriconazole and posaconazole.
- On the basis of dosage, the blastomycosis treatment market is segmented into tablet, injection, capsule and others.
- On the basis of route of administration, theblastomycosis treatment market is segmented into intravenous, oral and others.
- On the basis of diagnosis, the blastomycosis treatment market is segmented into chest CT scan, chest X-ray, skin biopsy, sputum culture and examination, urinary antigen detection, urine culture and others.
- On the basis of end-users, the blastomycosis treatment market is segmented into clinic, hospital and others.
The blastomycosis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Blastomycosis Treatment Market Country Level Analysis
Blastomycosis treatment market is analyzed and market size information is provided by the country, treatment, dosage, route of administration, diagnosis, end-users and distribution channel as referenced above.
The countries covered in the blastomycosis treatment market reportare the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the blastomycosis treatment market due to the presence of major key players, continuous technological development, well-developed healthcare sector, increasing prevalence of disease and increasing awareness towards health in this region. Asia-Pacific is expected to grow during the forecast period of 2021 to 2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Blastomycosis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Blastomycosis Treatment Market Share Analysis
Blastomycosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to blastomycosis treatment market.
The major players covered in the global blastomycosis treatment market report are Bristol-Myers Squibb Company, MATINAS BIOPHARMA HOLDINGS, INC., Nano-X Imaging LTD., Nanomerics, Abzena Ltd, Bharat Serums and Vaccines Limited (BSV), Astellas Pharma Inc., Leadiant Biosciences, Inc., Lilly, Inter Mune,Jina Pharmaceuticals, SteriMax, XGen Pharmaceuticals DJB, Inc., Novartis AG, Sanofi, Pfizer Inc.,Abbott, Bayer AG, Merck Sharp & Dohme Corp., GlaxoSmithKline plc, Thermo Fisher Scientific Inc., Aspen Biopharma Labs Pvt Ltd., and Enzon Pharmaceuticals, Inc.,among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-